MFN2 and cardiac hypertrophy: Mutations in the guanosine triphosphatase region of MFN2 are known to be associated with CMT2A [32]; however, mutations in the heptad repeat domain have been hypothesized to affect other organs, including heart [33], considering reported cardiac hypertrophy and enlargement in MFN2 gene-deficient mice [34,35].